[go: up one dir, main page]

ZA201408055B - Compositions and methods for the treatment of local pain - Google Patents

Compositions and methods for the treatment of local pain

Info

Publication number
ZA201408055B
ZA201408055B ZA2014/08055A ZA201408055A ZA201408055B ZA 201408055 B ZA201408055 B ZA 201408055B ZA 2014/08055 A ZA2014/08055 A ZA 2014/08055A ZA 201408055 A ZA201408055 A ZA 201408055A ZA 201408055 B ZA201408055 B ZA 201408055B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
methods
local pain
pain
Prior art date
Application number
ZA2014/08055A
Other languages
English (en)
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of ZA201408055B publication Critical patent/ZA201408055B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
ZA2014/08055A 2012-05-10 2014-11-04 Compositions and methods for the treatment of local pain ZA201408055B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1843CH2012 2012-05-10
PCT/IB2013/051268 WO2013168006A2 (fr) 2012-05-10 2013-02-16 Compositions et méthodes de traitement de la douleur locale

Publications (1)

Publication Number Publication Date
ZA201408055B true ZA201408055B (en) 2016-03-30

Family

ID=54193695

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/08055A ZA201408055B (en) 2012-05-10 2014-11-04 Compositions and methods for the treatment of local pain

Country Status (8)

Country Link
EP (1) EP2882745A2 (fr)
JP (1) JP2016508956A (fr)
CN (1) CN105612155A (fr)
AU (1) AU2013257727B2 (fr)
CA (1) CA2873138A1 (fr)
SG (1) SG11201407323WA (fr)
WO (1) WO2013168006A2 (fr)
ZA (1) ZA201408055B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
EP3406210B1 (fr) 2008-09-26 2024-10-16 Relievant Medsystems, Inc. Systèmes pour piloter un instrument à travers un os
WO2013101772A1 (fr) 2011-12-30 2013-07-04 Relievant Medsystems, Inc. Systèmes et méthodes de traitement de douleur dorsale
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
WO2014071161A1 (fr) 2012-11-05 2014-05-08 Relievant Medsystems, Inc. Système et méthodes de création de chemins incurvés à travers un os et de modulation des nerfs au sein de l'os
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
KR102422382B1 (ko) * 2016-12-26 2023-01-25 셀릭스 바이오 프라이빗 리미티드 통증 치료를 위한 조성물
AU2020346827A1 (en) 2019-09-12 2022-03-31 Relievant Medsystems, Inc. Systems and methods for tissue modulation
AU2021306313A1 (en) 2020-07-10 2023-03-02 Relievant Medsystems, Inc. Vertebral denervation in conjunction with vertebral fusion
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
US12039731B2 (en) 2020-12-22 2024-07-16 Relievant Medsystems, Inc. Prediction of candidates for spinal neuromodulation
US12433668B1 (en) 2021-11-08 2025-10-07 Relievant Medsystems, Inc. Impedance stoppage mitigation during radiofrequency tissue ablation procedures
GB202305212D0 (en) * 2023-04-06 2023-05-24 Elixa Mediscience Ltd Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
CN1187813A (zh) * 1995-05-01 1998-07-15 斯科舍集团有限公司 作为生物活性化合物的脂肪酸酯
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
CA2308495C (fr) * 1997-11-19 2009-01-06 Darwin Discovery Limited Formulation anesthesique
RS51031B (sr) * 2001-04-30 2010-10-31 Trommsdorff Gmbh & Co.Kg.Arzneimittel Farmaceutski aktivni estri uridina
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
US20120022147A1 (en) * 2011-08-17 2012-01-26 Krisani Biosciences (P) Ltd 2, 6 xylidine derivatives for the treatment of pain

Also Published As

Publication number Publication date
AU2013257727A1 (en) 2014-11-27
CN105612155A (zh) 2016-05-25
CA2873138A1 (fr) 2013-11-14
EP2882745A2 (fr) 2015-06-17
JP2016508956A (ja) 2016-03-24
WO2013168006A3 (fr) 2016-09-01
WO2013168006A2 (fr) 2013-11-14
SG11201407323WA (en) 2014-12-30
AU2013257727B2 (en) 2016-04-28

Similar Documents

Publication Publication Date Title
IL266582A (en) Preparations and methods for the treatment of hemoglobin diseases
IL261768B (en) Devices and methods for tissue treatment
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2675469A4 (fr) Compositions, dispositifs et procédés d'utilisation de celles-ci dans le traitement des cancers
EP2847152A4 (fr) Compositions et méthodes de traitement du syndrome métabolique
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
EP2890440A4 (fr) Dispositifs et procédés pour le traitement d'une maladie vasculaire
EP2831001A4 (fr) Compositions de traitement des eaux et procédés d'utilisation
GB201320723D0 (en) Composition and methods of treatment
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2958936A4 (fr) Méthodes et compositions pour le traitement de la maladie de forbes-cori
ZA201408056B (en) Compositions and methods for the treatment of mucositis
IL239921A0 (en) Preparations containing solutions in solid state and their use for the treatment of pain
IL239374B (en) Preparations and methods for treating brain tumors
PT2900230T (pt) Compostos para o tratamento de obesidade e métodos de utilização dos mesmos
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408065B (en) Compositions and methods for the treatment of diabetes
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome